Otonomy to Present at Cantor Fitzgerald Global Healthcare Conference

SAN DIEGO, Sept. 25, 2018 (GLOBE NEWSWIRE) -- Otonomy, Inc. (NASDAQ: OTIC), a biopharmaceutical company dedicated to the development of innovative therapeutics for otology, today announced that David A. Weber, Ph.D., president and chief executive officer, will present at the 2018 Cantor Fitzgerald Global Healthcare Conference on Tuesday, October 2, 2018 at 8:35 a.m. ET (5:35 a.m. PT) at the InterContinental New York Barclay Hotel in New York City.

A live audio webcast of the presentation will be available through the Events and Presentations page of the company's website (www.otonomy.com).

About OtonomyOtonomy is a biopharmaceutical company dedicated to the development of innovative therapeutics for otology. The company pioneered the application of drug delivery technology to the ear in order to develop products that achieve sustained drug exposure from a single local administration. This approach is covered by a broad patent estate and is being utilized to develop a pipeline of products addressing important unmet medical needs including Ménière’s disease, hearing loss, and tinnitus. For additional information please visit www.otonomy.com.

Contacts: Investor InquiriesWestwicke PartnersRobert H. UhlManaging Director858.356.5932[email protected]

You May Also Be Interested In

• Cantor Fitzgerald Starts Lexicon Pharmaceuticals (LXRX) at Overweight
• Tinghua Liquor’s Innovative Technology Receives Patent Recognition in Europe and the United States
• Robbyant and AFDE Sign MoU to Accelerate Embodied AI and Robotics Deployment Across the Middle East